SMTL ID : 2yng.1

HIV-1 Reverse Transcriptase in complex with inhibitor GSK560

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.12 Å

Oligo State

hetero-oligomer

Ligands

3 x MG: MAGNESIUM ION(Non-covalent)

MG.1: 5 residues within 4Å: Chain A: D.446, E.481, D.501 Ligands: MG.2, MG.3 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:D.446, A:E.481, A:D.501, A:D.501 MG.2: 6 residues within 4Å: Chain A: D.446, D.501, A.541, D.552, R.560 Ligands: MG.1 2 PLIP interactions: 2 interactions with chain A Metal complexes: A:D.446, A:D.501 MG.3: 6 residues within 4Å: Chain A: D.446, G.447, N.477, E.481, R.560 Ligands: MG.1 2 PLIP interactions: 2 interactions with chain A Metal complexes: A:G.447, A:E.481

1 x SRT: S,R MESO-TARTARIC ACID(Non-covalent)

SRT.4: 7 residues within 4Å: Chain A: V.438, G.439, A.440, N.463, R.464 Chain B: A.307, T.309 8 PLIP interactions: 6 interactions with chain A, 2 interactions with chain B Hydrogen bonds: A:G.439, A:N.463, B:T.309 Water bridges: A:A.440, A:T.442, A:N.497, B:T.309 Salt bridges: A:R.464

1 x WHU: 2-AZANYL-N-[[4-BROMANYL-3-(3-CHLORANYL-5-CYANO-PHENOXY)-2-FLUORANYL-PHENYL]METHYL]-4-CHLORANYL-1H-IMIDAZOLE-5-CARBOXAMIDE(Non-covalent)

WHU.5: 19 residues within 4Å: Chain A: P.98, L.103, K.104, K.105, K.106, K.107, S.108, V.109, V.111, Y.184, Y.191, V.192, G.193, F.230, W.232, L.237, H.238, P.239, Y.321 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:L.103, A:L.237 Hydrogen bonds: A:K.106, A:K.106, A:K.107, A:V.109, A:H.238 pi-Stacking: A:Y.191, A:W.232 Halogen bonds: A:L.237

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Chong, P. et al., Rational Design of Potent Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase. J.Med.Chem. (2012)

Release Date

2013-01-09

Peptides

REVERSE TRANSCRIPTASE/RIBONUCLEASE H: A
P51 RT: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

REVERSE TRANSCRIPTASE/RIBONUCLEASE H

P51 RT

Related Entries With Identical Sequence